Cargando…
Immunological Aspects of AXL/GAS‐6 in the Context of Human Liver Regeneration
AXL and its corresponding ligand growth arrest–specific 6 (GAS‐6) are critically involved in hepatic immunomodulation and regenerative processes. Pleiotropic inhibitory effects on innate inflammatory responses might essentially involve the shift of macrophage phenotype from a pro‐inflammatory M1 to...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870037/ https://www.ncbi.nlm.nih.gov/pubmed/34951136 http://dx.doi.org/10.1002/hep4.1832 |
_version_ | 1784656640465698816 |
---|---|
author | Ortmayr, Gregor Brunnthaler, Laura Pereyra, David Huber, Heidemarie Santol, Jonas Rumpf, Benedikt Najarnia, Sina Smoot, Rory Ammon, Daphni Sorz, Thomas Fritsch, Fabian Schodl, Michael Voill‐Glaninger, Astrid Weitmayr, Barbara Födinger, Manuela Klimpfinger, Martin Gruenberger, Thomas Assinger, Alice Mikulits, Wolfgang Starlinger, Patrick |
author_facet | Ortmayr, Gregor Brunnthaler, Laura Pereyra, David Huber, Heidemarie Santol, Jonas Rumpf, Benedikt Najarnia, Sina Smoot, Rory Ammon, Daphni Sorz, Thomas Fritsch, Fabian Schodl, Michael Voill‐Glaninger, Astrid Weitmayr, Barbara Födinger, Manuela Klimpfinger, Martin Gruenberger, Thomas Assinger, Alice Mikulits, Wolfgang Starlinger, Patrick |
author_sort | Ortmayr, Gregor |
collection | PubMed |
description | AXL and its corresponding ligand growth arrest–specific 6 (GAS‐6) are critically involved in hepatic immunomodulation and regenerative processes. Pleiotropic inhibitory effects on innate inflammatory responses might essentially involve the shift of macrophage phenotype from a pro‐inflammatory M1 to an anti‐inflammatory M2. We aimed to assess the relevance of the AXL/GAS‐6‐pathway in human liver regeneration and, consequently, its association with clinical outcome after hepatic resection. Soluble AXL (sAXL) and GAS‐6 levels were analyzed at preoperative and postoperative stages in 154 patients undergoing partial hepatectomy and correlated with clinical outcome. Perioperative dynamics of interleukin (IL)‐6, soluble tyrosine‐protein kinase MER (sMerTK), soluble CD163 (sCD163), and cytokeratin (CK) 18 were assessed to reflect pathophysiological processes. Preoperatively elevated sAXL and GAS‐6 levels predicted postoperative liver dysfunction (area under the curve = 0.721 and 0.722; P < 0.005) and worse clinical outcome. These patients failed to respond with an immediate increase of sAXL and GAS‐6 upon induction of liver regeneration. Abolished AXL pathway response resulted in a restricted increase of sCD163, suggesting a disrupted phenotypical switch to regeneratory M2 macrophages. No association with sMerTK was observed. Concomitantly, a distinct association of IL‐6 levels with an absent increase of AXL/GAS‐6 signaling indicated pronounced postoperative inflammation. This was further supported by increased intrahepatic secondary necrosis as reflected by CK18M65. sAXL and GAS‐6 represent not only potent and easily accessible preoperative biomarkers for the postoperative outcome but also AXL/GAS‐6 signaling might be of critical relevance in human liver regeneration. Refractory AXL/GAS‐6 signaling, due to chronic overactivation/stimulation in the context of underlying liver disease, appears to abolish their immediate release following induction of liver regeneration, causing overwhelming immune activation, presumably via intrahepatic immune regulation. |
format | Online Article Text |
id | pubmed-8870037 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88700372022-02-28 Immunological Aspects of AXL/GAS‐6 in the Context of Human Liver Regeneration Ortmayr, Gregor Brunnthaler, Laura Pereyra, David Huber, Heidemarie Santol, Jonas Rumpf, Benedikt Najarnia, Sina Smoot, Rory Ammon, Daphni Sorz, Thomas Fritsch, Fabian Schodl, Michael Voill‐Glaninger, Astrid Weitmayr, Barbara Födinger, Manuela Klimpfinger, Martin Gruenberger, Thomas Assinger, Alice Mikulits, Wolfgang Starlinger, Patrick Hepatol Commun Original Articles AXL and its corresponding ligand growth arrest–specific 6 (GAS‐6) are critically involved in hepatic immunomodulation and regenerative processes. Pleiotropic inhibitory effects on innate inflammatory responses might essentially involve the shift of macrophage phenotype from a pro‐inflammatory M1 to an anti‐inflammatory M2. We aimed to assess the relevance of the AXL/GAS‐6‐pathway in human liver regeneration and, consequently, its association with clinical outcome after hepatic resection. Soluble AXL (sAXL) and GAS‐6 levels were analyzed at preoperative and postoperative stages in 154 patients undergoing partial hepatectomy and correlated with clinical outcome. Perioperative dynamics of interleukin (IL)‐6, soluble tyrosine‐protein kinase MER (sMerTK), soluble CD163 (sCD163), and cytokeratin (CK) 18 were assessed to reflect pathophysiological processes. Preoperatively elevated sAXL and GAS‐6 levels predicted postoperative liver dysfunction (area under the curve = 0.721 and 0.722; P < 0.005) and worse clinical outcome. These patients failed to respond with an immediate increase of sAXL and GAS‐6 upon induction of liver regeneration. Abolished AXL pathway response resulted in a restricted increase of sCD163, suggesting a disrupted phenotypical switch to regeneratory M2 macrophages. No association with sMerTK was observed. Concomitantly, a distinct association of IL‐6 levels with an absent increase of AXL/GAS‐6 signaling indicated pronounced postoperative inflammation. This was further supported by increased intrahepatic secondary necrosis as reflected by CK18M65. sAXL and GAS‐6 represent not only potent and easily accessible preoperative biomarkers for the postoperative outcome but also AXL/GAS‐6 signaling might be of critical relevance in human liver regeneration. Refractory AXL/GAS‐6 signaling, due to chronic overactivation/stimulation in the context of underlying liver disease, appears to abolish their immediate release following induction of liver regeneration, causing overwhelming immune activation, presumably via intrahepatic immune regulation. John Wiley and Sons Inc. 2021-12-24 /pmc/articles/PMC8870037/ /pubmed/34951136 http://dx.doi.org/10.1002/hep4.1832 Text en © 2021 The Authors. Hepatology Communications published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Ortmayr, Gregor Brunnthaler, Laura Pereyra, David Huber, Heidemarie Santol, Jonas Rumpf, Benedikt Najarnia, Sina Smoot, Rory Ammon, Daphni Sorz, Thomas Fritsch, Fabian Schodl, Michael Voill‐Glaninger, Astrid Weitmayr, Barbara Födinger, Manuela Klimpfinger, Martin Gruenberger, Thomas Assinger, Alice Mikulits, Wolfgang Starlinger, Patrick Immunological Aspects of AXL/GAS‐6 in the Context of Human Liver Regeneration |
title | Immunological Aspects of AXL/GAS‐6 in the Context of Human Liver Regeneration |
title_full | Immunological Aspects of AXL/GAS‐6 in the Context of Human Liver Regeneration |
title_fullStr | Immunological Aspects of AXL/GAS‐6 in the Context of Human Liver Regeneration |
title_full_unstemmed | Immunological Aspects of AXL/GAS‐6 in the Context of Human Liver Regeneration |
title_short | Immunological Aspects of AXL/GAS‐6 in the Context of Human Liver Regeneration |
title_sort | immunological aspects of axl/gas‐6 in the context of human liver regeneration |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870037/ https://www.ncbi.nlm.nih.gov/pubmed/34951136 http://dx.doi.org/10.1002/hep4.1832 |
work_keys_str_mv | AT ortmayrgregor immunologicalaspectsofaxlgas6inthecontextofhumanliverregeneration AT brunnthalerlaura immunologicalaspectsofaxlgas6inthecontextofhumanliverregeneration AT pereyradavid immunologicalaspectsofaxlgas6inthecontextofhumanliverregeneration AT huberheidemarie immunologicalaspectsofaxlgas6inthecontextofhumanliverregeneration AT santoljonas immunologicalaspectsofaxlgas6inthecontextofhumanliverregeneration AT rumpfbenedikt immunologicalaspectsofaxlgas6inthecontextofhumanliverregeneration AT najarniasina immunologicalaspectsofaxlgas6inthecontextofhumanliverregeneration AT smootrory immunologicalaspectsofaxlgas6inthecontextofhumanliverregeneration AT ammondaphni immunologicalaspectsofaxlgas6inthecontextofhumanliverregeneration AT sorzthomas immunologicalaspectsofaxlgas6inthecontextofhumanliverregeneration AT fritschfabian immunologicalaspectsofaxlgas6inthecontextofhumanliverregeneration AT schodlmichael immunologicalaspectsofaxlgas6inthecontextofhumanliverregeneration AT voillglaningerastrid immunologicalaspectsofaxlgas6inthecontextofhumanliverregeneration AT weitmayrbarbara immunologicalaspectsofaxlgas6inthecontextofhumanliverregeneration AT fodingermanuela immunologicalaspectsofaxlgas6inthecontextofhumanliverregeneration AT klimpfingermartin immunologicalaspectsofaxlgas6inthecontextofhumanliverregeneration AT gruenbergerthomas immunologicalaspectsofaxlgas6inthecontextofhumanliverregeneration AT assingeralice immunologicalaspectsofaxlgas6inthecontextofhumanliverregeneration AT mikulitswolfgang immunologicalaspectsofaxlgas6inthecontextofhumanliverregeneration AT starlingerpatrick immunologicalaspectsofaxlgas6inthecontextofhumanliverregeneration |